She is advancing early detection of the BRCA cancer gene which has already saved many, including herself

Pamela Munster

Professor, Department of Medicine (Hematology/Oncology), UCSF, San Francisco, USA

Why you should listen

Dr. Munster’s clinical research’s interests are first-in human early phase clinical trials of novel compounds and alternative strategies for the treatment and prevention of cancer.

As the program leader for Development Therapeutics and the PI of a peer-reviewed basic science lab, her main focus is on translating preclinical findings into early-stage clinical trials.

Her basic research interest centers on the role of epigenetic modification in therapy resistance in breast cancer and epigenetic priming.

She is the author of the book “Twisting Fate: My Journey with BRCA — from Breast Cancer Doctor to Patient and Back”.

Hear Pamela speak at WORLDWEBFORUM 2020 as she tackles the complex issues of genetic testing for BRCA and provides thoughtful insights as to why one should pursue it.

About UCSF Health

UCSF Health is internationally renowned for providing highly specialized and innovative care.

Our family of care includes UCSF Helen Diller Medical Center at Parnassus Heights, UCSF Medical Center at Mount Zion and UCSF Medical Center at Mission Bay; UCSF Benioff Children’s Hospitals in Oakland and San Francisco; Langley Porter Psychiatric Hospital and Clinics; UCSF Benioff Children’s Physicians; and the UCSF Faculty Practice.

We are part of UC San Francisco, one of the top universities in the nation for health sciences research and higher education.

By bringing together the world’s leading experts in nearly every area of health, we are able to drive advancements in treatment and technology that benefit patients everywhere.


Pamela Munster is Co-Director of the Center for BRCA Research, a BRCA-focused clinical and research program at the Helen Diller Family Comprehensive Cancer Center at UCSF.

Dr. Munster received her medical degree from the University of Bern, Switzerland; completed her residency in Internal Medicine at Indiana University Medical Center, then moved to Memorial Sloan-Kettering Cancer Center, New York for her oncology and hematology fellowship.

She served at Memorial Sloan Kettering as a faculty member in the breast cancer program before joining the Division of Breast Oncology and Experimental Therapeutics Program at Moffitt Cancer Center and Research Institute, Tampa, Florida.

Currently, Dr. Munster is Professor in Residence at the University of California, San Francisco, where she is also the Director of Early Phase Clinical Trials Program at the Helen Diller Family Comprehensive Cancer Center and Program Leader of Experimental Therapeutics.